Breaking News Instant updates and real-time market news.

CRM

Salesforce

$72.77

-0.06 (-0.08%)

, ADBE

Adobe

$108.42

0.93 (0.87%)

20:11
10/18/16
10/18
20:11
10/18/16
20:11

Leaked Salesforce email reveals previous acquisition targets, WSJ says

A presentation included in leaked emails from Colin Powell, who sits on the Salesforce (CRM) board of directors, indicate the company was looking at 14 potential acquisition targets in May, reports the Wall Street Journal. The presentation, titled "M&A Target Review," names targets such as Adobe (ADBE), Pegasystems (PEGA), Demandware, ServiceNow (NOW), Tableau Software (DATA), Marketo, NetSuite (N), Qlik, Box (BOX), Zendesk (ZEN), Workday (WDAY) and LinkedIn (LNKD), which has agreed to be acquired by Microsoft (MSFT), the report said. A spokesperson for Pegasystems told the publication that "we have not had any discussions with Salesforce on the topic of acquisition." A spokesperson for Salesforce commented to the Journal that the presentation was merely a "landscape" of potential targets, and didn't indicate intent to buy. The report cautions that Box, Zendesk, and Workday were listed in the presentation alongside comments such as "CEO has no interest." Twitter (TWTR) was not named in the presentation, the report adds. Reference Link

CRM

Salesforce

$72.77

-0.06 (-0.08%)

ADBE

Adobe

$108.42

0.93 (0.87%)

PEGA

Pegasystems

$29.90

0.55 (1.87%)

NOW

ServiceNow

$76.16

1.52 (2.04%)

DATA

Tableau

$47.23

0.03 (0.06%)

N

NetSuite

$100.49

-0.03 (-0.03%)

BOX

Box

$14.49

-0.06 (-0.41%)

ZEN

Zendesk

$26.22

-0.43 (-1.61%)

WDAY

Workday

$86.54

0.46 (0.53%)

LNKD

LinkedIn

$190.38

-0.07 (-0.04%)

MSFT

Microsoft

$57.66

0.44 (0.77%)

TWTR

Twitter

$16.83

0.1 (0.60%)

  • 19

    Oct

  • 20

    Oct

  • 21

    Oct

  • 23

    Oct

  • 26

    Oct

  • 01

    Nov

  • 02

    Nov

  • 03

    Nov

  • 03

    Nov

  • 08

    Nov

  • 08

    Nov

  • 14

    Nov

  • 30

    Nov

  • 30

    Nov

  • 08

    Dec

  • 12

    Dec

  • 15

    Dec

CRM Salesforce
$72.77

-0.06 (-0.08%)

10/14/16
RAJA
10/14/16
NO CHANGE
RAJA
Raymond James said Salesforce not bidding for Twitter a significant positive
Raymond James said reports Salesforce (CRM) will not bid for Twitter (TWTR) is a significant positive for shares and could set the stage for a sustained stock recovery and breakout in the stock.
10/18/16
RSBL
10/18/16
INITIATION
Target $90
RSBL
Buy
Salesforce initiated with a Buy at Rosenblatt
Rosenblatt analyst Marshall Senk initiated Salesforce.com with a Buy and a $90 price target. The analyst believes Q2 weakness will prove to be a short-term issue and said the company is rebounding strongly here in Q3 and is setup well for the fourth quarter. Further, he has confidence in FY18 sales of $10B driven by customer adoption, as supported by the balance sheet.
10/10/16
JPMS
10/10/16
NO CHANGE
Target $95
JPMS
Overweight
JPMorgan sees 'opportune entry point' for Salesforce
JPMorgan analyst Mark Murphy believes shares of Salesforce (CRM) are at an "'opportune entry point" following the recent selloff. The pullback has been driven by a "slightly soft" Q2 and concerns about a potentially expensive acquisition of Twitter (TWTR), Murphy tells investors in a research note. After speaking to industry contacts at Dreamforce, the analyst sees a path for the "overhangs to fade" with a "better pace of business in Q3/Q4" as well as the eventual fading of the Twitter discussion. Murphy reiterates an Overweight rating on Salesforce with a $95 price target in a research note titled "The Most Valuable Cloud Asset Is Undeservedly Undervalued."
10/07/16
ADAM
10/07/16
NO CHANGE
Target $95
ADAM
Buy
Salesforce worthy of investor consideration at current levels, says Canaccord
Canaccord analyst Richard Davis came away from the Salesforce (CRM) Dreamforce week more enthused about the company's outlook. The analyst noted the company is growing its revenues 3.5 times faster than it legacy peers. Davis noted the company's CEO said they are very disciplined on price when it comes to acquisitions and believes that they would not be interested in Twitter (TWTR) at its rumored asking price of $28 per share. Davis reiterated his Buy rating and $95 price target on Salesforce shares.
ADBE Adobe
$108.42

0.93 (0.87%)

09/21/16
JPMS
09/21/16
NO CHANGE
Target $122
JPMS
Overweight
Adobe price target raised to $122 from $110 at JPMorgan
JPMorgan analyst Sterling Auty raised his price target for Adobe Systems to $122 saying the company's "strong" Q3 results should alleviate recent investor concerns. Momentum in Creative Cloud and digital marketing position the stock well for a Q4 "push," Auty tells investors in a post-earnings research note. He keeps an Overweight rating on the shares.
09/21/16
UBSW
09/21/16
NO CHANGE
Target $130
UBSW
Buy
Adobe price target raised to $130 from $122 at UBS
UBS analyst Brent Thill raised his price target on Adobe to $130 from $122 following Q3 results he called strong. The firm sees continued momentum in several businesses, including Creative Cloud, Marketing Cloud, and Document Cloud. Thill reiterated his Buy rating on Adobe shares.
09/21/16
JMPS
09/21/16
NO CHANGE
JMPS
Adobe price target raised to $120 from $106 at JMP Securities
JMP Securities analyst Patrick Walravens says that Adobe reported :strong" Q3 results that restored his confidence in the stock. The analyst remains upbeat on the company's long-term outlook and keeps an Outperform rating on the shares.
09/21/16
ADAM
09/21/16
NO CHANGE
Target $120
ADAM
Buy
Adobe price target raised to $120 from $110 at Canaccord
Canaccord analyst Richard Davis raised his price target on Adobe to $120 from $110 following the company's Q3 earnings report. The analyst remains excited about the company, which he views as the definitive leader in digital content creation, adding that with the emergence of inbound marketing, content has been crucial to marketing success. Davis, who expects Adobe to continue to grow revenues in the low 20% range next year, reiterated his Buy rating on Adobe shares.
PEGA Pegasystems
$29.90

0.55 (1.87%)

11/16/15
WEDB
11/16/15
NO CHANGE
WEDB
Pegasystems CFO resignation 'relatively benign,' says Wedbush
After Pegasystems announced the resignation of its CFO, Wedbush says that the implications for the company are "relatively benign." The firm says that the company's outgoing CFO is pursuing a good opportunity at a pre-IPO tech company, and his departure does not reflect poorly on Pegasystems. The firm keeps a $30 price target and Outperform rating on the shares.
NOW ServiceNow
$76.16

1.52 (2.04%)

09/19/16
BMOC
09/19/16
INITIATION
BMOC
Market Perform
ServiceNow initiated with a Market Perform at BMO Capital
09/15/16
GUGG
09/15/16
INITIATION
Target $90
GUGG
Buy
ServiceNow initiated with a Buy at Guggenheim
Guggenheim analyst Ryan Hutchinson initiated ServiceNow with a Buy and a $90 price target.
10/18/16
PIPR
10/18/16
NO CHANGE
Target $90
PIPR
Overweight
Piper sees ServiceNow Q3 earnings report as catalyst
Piper Jaffray analyst Alex Zukin says his recent conversations with industry partners indicate "strong" renewal and net new business in ServiceNow's (NOW) Q3. He expects the company to outperform consensus expectations. Zukin sees the earnings report as a catalyst and points out that shares of ServiceNow are down 12% year-to-date while trading at a 14% discount to Workday (WDAY). The analyst reiterates an Overweight rating on ServiceNow with a $90 price target.
10/12/16
OTRG
10/12/16
DOWNGRADE
OTRG
Mixed
ServiceNow downgraded to Mixed from Positive at OTR Global
DATA Tableau
$47.23

0.03 (0.06%)

09/14/16
OPCO
09/14/16
NO CHANGE
Target $62
OPCO
Outperform
Oppenheimer remains positive on Tableau long-term opportunity
Oppenheimer analyst Ittai Kidron says he remains positive on Tableau's long-term opportunity after meeting with the company's management, but notes that investors may need to build in a multiple-quarter view. He says the key is execution and recommends buying ahead of proof points given the size of the BI/Analytics opportunity and ongoing signs of Tableau's differentiation. Kidron reiterates an Outperform rating and $62 price target on the shares.
09/30/16
COWN
09/30/16
NO CHANGE
COWN
Hortonworks checks 'concerning,' quarter at risk, says Cowen
Cowen analyst J. Derrick Wood said his checks suggest there have been many high-level employee departures at Hortonworks (HDP) and he also thinks that sales productivity is constrained, presenting risk to its quarterly results. Meanwhile, he said that his checks on Teradata (TDC) remain constructive, noting that he is hearing the company is already signing orders for cloud with its core analytical database products now available on AWS. There are "some encouraging data points" for Tableau (DATA), said Wood, who added that he still has more field work to do around its quarter.
08/25/16
RBCM
08/25/16
DOWNGRADE
RBCM
Sector Perform
Tableau downgraded on cloud transition, competition at RBC Capital
As noted earlier, RBC Capital downgraded Tableau to Sector Perform from Outperform. As reasons for the downgrade, analyst Matthew Hedberg cited the company's transition to the cloud and increased competition. Additionally, the analyst believes that a takeover has become less likely after the company named a new CEO. Target $65.
08/25/16
RBCM
08/25/16
DOWNGRADE
RBCM
Sector Perform
Tableau downgraded to Sector Perform from Outperform at RBC Capital
N NetSuite
$100.49

-0.03 (-0.03%)

09/13/16
JMPS
09/13/16
NO CHANGE
JMPS
NetSuite takeover price likely to increase, says JMP Securities
JMP Securities analyst Patrick Walravens believes that Oracle's (ORCL) $109 takeover offer for NetSuite (N) will probably increase, partly because a majority of shares owned by those who are not insiders must vote to approve the transaction. The analyst notes that T. Rowe Price (TROW), which controls 18% of such shares, opposes the deal at the current price. Walravens adds that NetSuite appears to have failed to "canvas the market," as required by Delaware law. He raised his price target on NetSuite to $121 from $100 and keeps an Outperform rating on the stock.
08/02/16
MKMP
08/02/16
DOWNGRADE
MKMP
Neutral
NetSuite downgraded to Neutral from Buy at MKM Partners
MKM Partners downgraded NetSuite (N) following the proposed acquisition by Oracle (ORCL) for $109 per share.
07/29/16
COWN
07/29/16
UPGRADE
Target $109
COWN
Market Perform
NetSuite upgraded to Market Perform from Underperform at Cowen
Cowen upgraded NetSuite (N) to Market Perform from Underperform following the proposed acquisition by Oracle (ORCL) for $109 per share.
07/29/16
RAJA
07/29/16
UPGRADE
RAJA
Market Perform
NetSuite upgraded to Market Perform from Underperform at Raymond James
BOX Box
$14.49

-0.06 (-0.41%)

09/09/16
OPCO
09/09/16
NO CHANGE
Target $18
OPCO
Outperform
Oppenheimer bullish on Box, Google collaboration
Oppenheimer analyst Ittai Kidron is "incrementally positive" on Box (BOX) after attending its BoxWorks conference and analyst day, and says he remains bullish on 2018 opportunities for upside as new products gain traction. Additionally, the analyst is bullish on the newly announced Google (GOOG; GOOGL) integration, saying it not only closes a platform gap and enhances SMB coverage, but reinforces Box's enterprise leadership. Kidron reiterates an Outperform rating and $18 price target on Box's shares.
09/15/16
MUFG
09/15/16
INITIATION
MUFG
Neutral
Box initiated with a Neutral at MUFG
MUFG analysts Stephen Bersey and Daniel Clark initiated Box with a Neutral rating and a $15 price target.
09/26/16
RSBL
09/26/16
INITIATION
Target $25
RSBL
Buy
Box initiated with a Buy at Rosenblatt
Rosenblatt analyst Marshall Senk initiated Box with a Buy and a $25 price target.
06/02/16
JMPS
06/02/16
NO CHANGE
JMPS
Box weakness creates buying opportunity, says JMP Securities
JMP Securities notes that Box reported higher than expected Q1 revenue but lower than expected billings. The firm says that the billings miss caused the stock to drop about 7% in after-hours trading. The firm recommends using the weakness in the stock as a buying opportunity. It believes that the company can continue growing at a 25% clip for a significant amount of time, while it has significant leverage. JMP keeps an $18 price target and Outperform rating on the shares.
ZEN Zendesk
$26.22

-0.43 (-1.61%)

06/23/16
UBSW
06/23/16
INITIATION
Target $32
UBSW
Buy
Zendesk initiated with a Buy at UBS
UBS analyst Brent Thill initiated Zendesk with a Buy and $32 price target. The analyst believes that Zendesk's suite of cloud-based customer support and engagement software applications will increasingly be viewed as a strategic differentiator and an asset that drives revenues from consumers who interact with support teams and net new prospects who hear positive reviews via connected channels such as the internet or social media.
08/03/16
PIPR
08/03/16
NO CHANGE
Target $35
PIPR
Overweight
Zendesk less big beat likely to weigh on shares, says Piper Jaffray
Piper Jaffray analyst Alex Zukin believes the decreasing magnitude of Zendesk's beat in Q2 will likely weigh on the stock today. The company's $1M billings beat relative to consensus expectations is well below the $4M-$5M beats the Street has seen over the past year, Zukin tells investors in a post-earnings research note. The analyst, however, sees a favorable setup in the second half of 2016 and views the concerns as overdone. He reiterates an Overweight rating on Zendesk with a $35 price target.
08/01/16
JMPS
08/01/16
NO CHANGE
JMPS
Zendesk price target raised to $33 from $28 at JMP Securities
JMP Securities analyst Patrick Walravens increased his price target on Zendesk, as he says that checks have uncovered five positive data points and zero negative data points about the company. The analyst thinks that the company is continuing to gain share, and he keeps an Outperform rating on the stock.
07/18/16
STFL
07/18/16
INITIATION
STFL
Hold
Zendesk initiated with a Hold at Stifel
WDAY Workday
$86.54

0.46 (0.53%)

09/28/16
09/28/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Workday (WDAY) upgraded to Neutral from Underperform at Wedbush with analyst Steve Koenig citing second-half 2016 sales potential, following a first-half which he thinks wasn't as good as generally perceived. 2. Dillard's (DDS) upgraded to Outperform from Neutral at Credit Suisse with analyst Michael Exstein citing the company's consistency in capital allocation and its valuation, which he says is at the low end of its historic trading range. 3. Cypress Energy (CELP) upgraded to Buy from Hold at Stifel analyst Michael Hoffman saying the CEO is upbeat on the company's outlook and its ability to maintain its distribution at current levels. 4. Huntington Bancshares (HBAN) upgraded to Buy from Hold at Deutsche Bank with analyst Matt O'Connor saying the 15% pullback in the shares since the FirstMerit (FMER) deal was announced is overdone. 5. Hi-Crush Partners (HCLP) upgraded to Neutral from Sell at UBS with analyst Shneur Gershuni saying recent commentary from oil field service companies indicate an increase in sand demand and intensity. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/30/16
OPCO
09/30/16
NO CHANGE
Target $100
OPCO
Outperform
Workday price target raised to $100 from $90 at Oppenheimer
Oppenheimer analyst Brian Schwartz raised his price target for Workday to $100 saying his customer survey makes him "increasingly comfortable" with the company's current business momentum. The analyst is "optimistic "about bookings and growth trends and sees low risk to estimates. Schwartz continues to view Workday as top 2016 pick with an Outperform rating.
10/03/16
ADAM
10/03/16
NO CHANGE
Target $110
ADAM
Buy
Workday price target raised to $110 from $98 at Canaccord
Canaccord analyst Richard Davis raised his price target on Workday to $110 from $98 as the company has grown into its current valuation and the stock will continue to advance on a sustainable basis in a bullish environment. Davis reiterated his Buy rating on Workday shares.
LNKD LinkedIn
$190.38

-0.07 (-0.04%)

06/15/16
UBSW
06/15/16
DOWNGRADE
Target $196
UBSW
Neutral
LinkedIn downgraded to Neutral from Buy at UBS
UBS analyst Eric Sheridan downgraded LinkedIn (LNKD) to Neutral saying it is unlikely that another bidder to Microsoft (MSFT) will emerge. The analyst, however, "cannot completely rule out this possibility." He raised his price target for LinkedIn shares to $196 from $175.
06/15/16
NOMU
06/15/16
DOWNGRADE
NOMU
Neutral
LinkedIn downgraded to Neutral from Buy at Nomura
LinkedIn (LNKD) is being acquired by Microsoft (MSFT) for $196 per share in cash.
09/23/16
BOFA
09/23/16
NO CHANGE
Target $55
BOFA
Buy
BofA thinks Verizon deal stays on track despite Yahoo data breach
Bank of America Merrill Lynch analyst Justin Post said that Yahoo's (YHOO) disclosure of the massive data breach impacting over 500M of its users is clearly a negative for the company that could result in email account closures, but he does not anticipate a major impact on Yahoo's business related to this breach, citing as evidence the fact that he is not aware of any significant business impairment or financial liability related to security breaches at LinkedIn (LNKD) in 2012 and at eBay (EBAY) in 2014. Post adds that the Target (TGT) data breach, which did include credit card info, is not directly comparable to Yahoo's breach. For Verizon (VZ) to back out of its acquisition agreement, Post thinks the company would need to assume Yahoo acted in bad faith during negotiations and that the Yahoo asset is impaired or comes with significant liability, neither of which he sees as being the case. The analyst keeps a Buy rating on Yahoo and bumped his target on the shares to $55 from $53, citing an increased price target on Alibaba (BABA) that a peer at the firm recently set.
06/15/16
RBCM
06/15/16
DOWNGRADE
RBCM
Sector Perform
LinkedIn downgraded to Sector Perform from Outperform at RBC Capital
LinkedIn (LNKD) is being acquired by Microsoft (MSFT) for $196 per share in cash.
MSFT Microsoft
$57.66

0.44 (0.77%)

10/06/16
OPCO
10/06/16
NO CHANGE
OPCO
Microsoft, Amazon well positioned to enable cloud, AI trends, says Oppenheimer
Oppenheimer analyst Timothy Horan notes that machine learning and artificial intelligence have been use to improve applications and acceleration of infrastructure builds, with "intelligent software" designed to make lives easier and more productive. Further, the analyst sees communications and cloud services continuing to converge, with infrastructure and data as key components to AI. Microsoft (MSFT) and Amazon (AMZN) Web Service are well positioned to enable these trends, he contends, adding that he see colocation providers, such as Equinix (EQIX) and Interxion (INXN), and networking companies like Zayo Group (ZAYO) GTT Communications (GTT) as beneficiaries.
10/13/16
NOMU
10/13/16
NO CHANGE
Target $65
NOMU
Buy
Microsoft expected to report a solid quarter, says Nomura
Nomura analyst Frederick Grieb expects Microsoft to report a solid Q1 driven by strong performance in Productivity and Business Process andIntelligent Cloud along with continued, single-digit declines in More Personal Computing results. The firm's reseller survey indicates Microsoft came in above plan for the quarter as resellers were positive on the Office 365 model transition. Grieb believes the transition to Office 365 is above plan, declines in the Windows business have likely moderated and the company should continue to outperform on operating expenses. The analyst rates Microsoft a Buy with a $65 price target.
09/26/16
CANT
09/26/16
NO CHANGE
Target $42
CANT
Buy
Yelp takeout chances increased with share conversion, says Cantor
Yelp's (YELP) conversion of Class B super-voting shares into regular Class A shares late last week increases the company's takeout potential, Cantor Fitzgerald analyst Youssef Squali tells investors in a research note. Yelp, especially following recent improvements in the underlying growth fundamentals of the business, has become "an easier, and more likely" acquisition target, the analyst contends. The analyst views Facebook (FB), Priceline (PCLN), TripAdvisor (TRIP) and Microsoft (MSFT) as potential acquirers of Yelp. Squali estimates Yelp could be worth $53 per share in a takeout. He keeps a Buy rating on the stock with a $42 price target. The stock is up 2% to $40.35 in early trading.
10/12/16
WELS
10/12/16
NO CHANGE
WELS
Market Perform
Wells doesn't see Apple as biggest beneficiary from Samsung issues
Wells Fargo analyst Maynard Um attributes the recent rally in shares of Apple (AAPL), at least in part, to Samsung's (SSNLF) issues with its Note 7 phones. Apple gained an incremental $14B in market capitalization at its intraday peak, which the analyst believes embeds more than 3M of incremental iPhone 7 Plus units. Samsung's production halt will help Apple, but other Android vendors with 5.7 inch phones could see a bigger benefit if Android users prefer to stick with Android, Um tells investors in a research note. He points out that LG, Kyocera, and Microsoft (MFST) have 5.7 inch Android phones at U.S. carriers. Um thinks expectations for Apple into earnings "have risen materially." He keeps a Market Perform rating on the iPhone maker. Apple closed yesterday up 25c to $116.30.
TWTR Twitter
$16.83

0.1 (0.60%)

10/11/16
DBAB
10/11/16
NO CHANGE
Target $22
DBAB
Buy
Twitter guidance could meet, exceed estimates, says Deutsche Bank
Deutsche Bank analyst Ross Sandler says that for the first time in a year, Twitter's guidance could meet or exceed consensus expectations. The analyst sees a good risk/reward profile for shares into the company's Q3 results. He notes that his channel checks point to a "high-end of the range" revenue with "slightly up" monthly active users for Q3. Twitter's NFL live video project "has been by all accounts a smashing success," Sandler tells investors in a research note. He keep a Buy rating on Twitter with a $22 price target.
10/11/16
10/11/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Twitter (TWTR) upgraded to Hold from Sell at Evercore ISI with analyst Ken Sena citing the recent pullback in the shares. 2. Tyson Foods (TSN) upgraded to Outperform from Market Perform at BMO Capital with analyst Kenneth Zaslow saying he thinks that the company's "strong underlying fundamentals" should enable its fiscal 2017 profits to beat expectations, and he says that the shares are undervalued. 3. Virgin America (VA) upgraded to Neutral from Underweight at JPMorgan with analyst Jamie Baker saying regulatory approval of the pending Alaska Air (ALK) takeover "remains more likely than not." 4. Cummins (CMI) was upgraded to Conviction Buy from Neutral and Caterpillar (CAT) was upgraded to Buy from Neutral at Goldman. 5. Carbonite (CARB) upgraded to Outperform from Perform at Oppenheimer with analyst Brian Schwartz saying he sees "substantial upside" from current levels due to valuation and fundamentals. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/11/16
EVER
10/11/16
UPGRADE
Target $17
EVER
Hold
Twitter upgraded to Hold from Sell at Evercore ISI
Evercore ISI analyst Ken Sena upgraded Twitter (TWTR) to Neutral citing the recent pullback in the shares. The analyst notes that the selloff "from a stalled sale process" has put the stock more in-line with his unchanged price target of $17. Sena thinks Twitter's guidance for Q3 "may prove sufficiently conservative."

TODAY'S FREE FLY STORIES

09:15
12/03/16
12/03
09:15
12/03/16
09:15
General news
Breaking General news story  »

New York Federal Reserve…

09:15
12/03/16
12/03
09:15
12/03/16
09:15
General news
Breaking General news story  »

New York Federal Reserve…

04:55
12/03/16
12/03
04:55
12/03/16
04:55
General news
Breaking General news story  »

New York Federal Reserve…

04:55
12/03/16
12/03
04:55
12/03/16
04:55
General news
Breaking General news story  »

New York Federal Reserve…

BMRN

BioMarin

$82.21

-1.12 (-1.34%)

, ESALY

Eisai

$57.91

0.59 (1.03%)

04:55
12/03/16
12/03
04:55
12/03/16
04:55
Conference/Events
American Epilepsy Society to hold annual meeting »

70th Annual Meeting of…

BMRN

BioMarin

$82.21

-1.12 (-1.34%)

ESALY

Eisai

$57.91

0.59 (1.03%)

GWPH

GW Pharmaceuticals

$112.32

3.04 (2.78%)

IART

Integra LifeSciences

$75.78

-1.07 (-1.39%)

MDT

Medtronic

$72.01

0.13 (0.18%)

MNK

Mallinckrodt

$53.61

0.51 (0.96%)

NVTA

Invitae

$6.95

0.16 (2.36%)

SAGE

SAGE Therapeutics

$49.02

-0.23 (-0.47%)

WTKWY

Wolters Kluwer

$34.08

-0.39 (-1.13%)

ZGNX

Zogenix

$13.05

0.35 (2.76%)

ZYNE

Zynerba

$13.64

0.83 (6.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

  • 05

    Dec

  • 06

    Dec

  • 07

    Dec

  • 12

    Dec

  • 14

    Dec

  • 28

    Jan

  • 27

    Apr

WMT

Wal-Mart

$70.88

0.21 (0.30%)

18:17
12/02/16
12/02
18:17
12/02/16
18:17
Periodicals
Wal-Mart to pay $7.5M to settle same-sex spouse benefit case, Reuters reports »

Wal-Mart said it would…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GMED

Globus Medical

$21.89

0.12 (0.55%)

, TLN

Talen Energy

18:14
12/02/16
12/02
18:14
12/02/16
18:14
Hot Stocks
S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices »

S&P Dow Jones Indices…

GMED

Globus Medical

$21.89

0.12 (0.55%)

TLN

Talen Energy

UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

IM

Ingram Micro

$38.88

1.31 (3.49%)

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$111.96

0.58 (0.52%)

, ALIOF

Actelion

$206.01

15.21 (7.97%)

18:11
12/02/16
12/02
18:11
12/02/16
18:11
Periodicals
Johnson & Johnson said to raise offer for Actelion above $250, Bloomberg says »

Johnson &…

JNJ

Johnson & Johnson

$111.96

0.58 (0.52%)

ALIOF

Actelion

$206.01

15.21 (7.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$79.10

0.3 (0.38%)

18:00
12/02/16
12/02
18:00
12/02/16
18:00
Hot Stocks
Celanese to raise list, off-list selling prices for paraformaldehyde »

Celanese Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

, GMED

Globus Medical

$21.89

0.12 (0.55%)

17:56
12/02/16
12/02
17:56
12/02/16
17:56
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: HomeStreet…

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

GMED

Globus Medical

$21.89

0.12 (0.55%)

BGS

B&G Foods

$42.50

0.2 (0.47%)

ZEN

Zendesk

$21.17

0.34 (1.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

  • 09

    Jan

ZEN

Zendesk

$21.17

0.34 (1.63%)

17:53
12/02/16
12/02
17:53
12/02/16
17:53
Hot Stocks
Zendesk says SVPs Amanda Kleha and Marcus Bragg to resign »

On November 29, Amanda…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

AIXG

Aixtron

$3.97

-0.05 (-1.24%)

17:42
12/02/16
12/02
17:42
12/02/16
17:42
Periodicals
President Obama blocks China's Fujian from acquiring Aixtron, CNBC reports »

President Barack Obama…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CX

CEMEX

$7.83

0.09 (1.16%)

17:31
12/02/16
12/02
17:31
12/02/16
17:31
Hot Stocks
CEMEX to divest ready-mix concrete pumping assets in Mexico »

CEMEX announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRNE

Sorrento Therapeutics

$5.15

-0.1 (-1.90%)

17:30
12/02/16
12/02
17:30
12/02/16
17:30
Syndicate
Breaking Syndicate news story on Sorrento Therapeutics »

Sorrento files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

MBRX

Moleculin Biotech

$2.63

-0.14 (-5.05%)

17:29
12/02/16
12/02
17:29
12/02/16
17:29
Syndicate
Breaking Syndicate news story on Moleculin Biotech »

Moleculin Biotech files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

NEOG

Neogen

$61.59

-1.46 (-2.32%)

17:28
12/02/16
12/02
17:28
12/02/16
17:28
Hot Stocks
Neogen acquires U.K.-based Quat-Chem, terms undisclosed »

Neogen announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RRC

Range Resources

$36.36

-0.23 (-0.63%)

17:25
12/02/16
12/02
17:25
12/02/16
17:25
Hot Stocks
Breaking Hot Stocks news story on Range Resources »

SailingStone Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EOG

EOG Resources

$103.74

-1.01 (-0.96%)

17:25
12/02/16
12/02
17:25
12/02/16
17:25
Syndicate
Breaking Syndicate news story on EOG Resources »

EOG Resources files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

, UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

17:22
12/02/16
12/02
17:22
12/02/16
17:22
Hot Stocks
Breaking Hot Stocks news story on HomeStreet, UMB Financial »

HomeStreet to replace UMB…

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

, IM

Ingram Micro

$38.88

1.31 (3.49%)

17:21
12/02/16
12/02
17:21
12/02/16
17:21
Hot Stocks
UMB Financial to replace Ingram Micro in S&P 400 as of 12/6 close »

Tianjin Tianhai…

UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

IM

Ingram Micro

$38.88

1.31 (3.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GMED

Globus Medical

$21.89

0.12 (0.55%)

, TLN

Talen Energy

17:20
12/02/16
12/02
17:20
12/02/16
17:20
Hot Stocks
Globus Medical to replace Talen Energy in S&P 400 as of 12/6 close »

Riverstone Holdings is…

GMED

Globus Medical

$21.89

0.12 (0.55%)

TLN

Talen Energy

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIXG

Aixtron

$3.97

-0.05 (-1.24%)

17:16
12/02/16
12/02
17:16
12/02/16
17:16
Periodicals
President Obama blocks China's takeover of Aixtron, CNBC reports »

Says the transaction…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DB

Deutsche Bank

$15.74

-0.32 (-1.99%)

17:07
12/02/16
12/02
17:07
12/02/16
17:07
Periodicals
Deutsche Bank to pay $60M settlement over gold price-fixing case, Reuters says »

Deutsche Bank will pay…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

ALB

Albemarle

$84.86

-0.79 (-0.92%)

17:07
12/02/16
12/02
17:07
12/02/16
17:07
Hot Stocks
Albemarle to increase prices for select brominated products »

Albemarle announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Mar

FOR

Forestar Group

$13.40

0.2 (1.52%)

17:06
12/02/16
12/02
17:06
12/02/16
17:06
Hot Stocks
Breaking Hot Stocks news story on Forestar Group »

Carlson Capital lowers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.